Full Text View
Tabular View
No Study Results Posted
Related Studies
Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction
This study has been completed.
Study NCT00213148   Information provided by EMD Serono

First Received on September 13, 2005.   Last Updated on August 23, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anovulation
More general conditions related to this trial
Adnexal Diseases
Endocrine System Diseases
Genital Diseases, Female
Gonadal Disorders
Ovarian Diseases
Interventions listed in this trial
Anastrozole 1mg
Anastrozole 5mg dose
Anastrozole 10mg dose
Clomiphene Citrate 50mg
Additional drug interventions recognized in this trial
Anastrozole
Aromatase Inhibitors
Citric Acid
Clomiphene
More general drug interventions related to this trial
Anticoagulants
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Chelating Agents
Enzyme Inhibitors
Estrogen Antagonists
Estrogen Receptor Modulators
Fertility Agents
Fertility Agents, Female
Hematologic Agents
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Selective Estrogen Receptor Modulators
Therapeutic Uses
Sponsors listed in this trial
EMD Serono


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services